FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

900000000000490003: Description inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001069012 Description inactivation indicator attribute value reference set en Synonym Active Case insensitive SNOMED CT model component
900000000001070013 Description inactivation indicator reference set en Synonym Active Case insensitive SNOMED CT model component
900000000001071012 Description inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED CT model component


584245 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Description inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members conceptInactivationValue
sodium chloride 6.4 mg/mL + potassium chloride 750 microgram/mL + calcium chloride dihydrate 480 microgram/mL + magnesium chloride 300 microgram/mL + sodium acetate 3.9 mg/mL + sodium citrate dihydrate 1.7 mg/mL eye solution, 120 mL Outdated
sodium chloride 6.43 g/L + potassium chloride 1.19 g (potassium 16 mmol)/L + magnesium chloride hexahydrate 3.25 g (magnesium 16 mmol)/L + calcium chloride dihydrate 176 mg (calcium 1.2 mmol)/L perfusion solution, 1 L bag Outdated
sodium chloride 6.43 g/L + potassium chloride 1.19 g (potassium 16 mmol)/L + magnesium chloride hexahydrate 3.25 g (magnesium 16 mmol)/L + calcium chloride dihydrate 176 mg (calcium 1.2 mmol)/L perfusion solution, 12 x 1 L bags Outdated
sodium chloride 6.43 g/L + potassium chloride 1.19 g (potassium 16 mmol)/L + magnesium chloride hexahydrate 3.25 g (magnesium 16 mmol)/L + calcium chloride dihydrate 176 mg (calcium 1.2 mmol)/L perfusion solution, bag Outdated
sodium chloride 7.04 mg / 1 g nasal gel (medicinal product unit of use) Outdated
sodium chloride 7.04 mg / 1 g nasal gel, 15 g (medicinal product pack) Outdated
sodium cromoglycate 1 mg / 1 actuation pressurised inhalation, 200 actuations (medicinal product pack) Outdated
sodium cromoglycate 1 mg / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Outdated
sodium cromoglycate 1 mg/actuation pressurised inhalation, 200 actuations Outdated
sodium cromoglycate 1 mg/actuation pressurised inhalation, actuation Outdated
sodium cromoglycate 5 mg / 1 actuation pressurised inhalation, 112 actuations (medicinal product pack) Outdated
sodium cromoglycate 5 mg / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Outdated
sodium cromoglycate 5 mg/actuation pressurised inhalation, 112 actuations Outdated
sodium cromoglycate 5 mg/actuation pressurised inhalation, actuation Outdated
sorbide nitrate Nonconformance to editorial policy component
soy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% eye spray Outdated
soy lecithin 1% + tocopherol 0.002% + vitamin A palmitate 0.025% eye spray, 100 actuations Outdated
soy lecithin 10 mg / 1 mL + tocopherol 20 microgram / 1 mL + vitamin A palmitate 250 microgram / 1 mL eye spray (medicinal product unit of use) Outdated
soy lecithin 10 mg / 1 mL + tocopherol 20 microgram / 1 mL + vitamin A palmitate 250 microgram / 1 mL eye spray, 100 actuations (medicinal product pack) Outdated
ssDNA binding autoantibody level Concept non-current
ssDNA binding autoantibody level Concept non-current
ssDNA binding autoantibody level (procedure) Concept non-current
ssDNA binding autoantibody level (procedure) Concept non-current
ssRNA phage virus Concept non-current
starch 250 mg / 1 g + talc 500 mg / 1 g + zinc oxide 250 mg / 1 g dusting powder (medicinal product unit of use) Outdated
starch 250 mg / 1 g + talc 500 mg / 1 g + zinc oxide 250 mg / 1 g dusting powder, 100 g (medicinal product pack) Outdated
stat Concept non-current
stated Outdated
stated (defining characteristic type) Outdated
sumatriptan 6 mg / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Outdated
sumatriptan 6 mg / 0.5 mL injection, 1 x 0.5 mL injection device (medicinal product pack) Outdated
sumatriptan 6 mg / 0.5 mL injection, 2 x 0.5 mL injection devices (medicinal product pack) Outdated
sumatriptan 6 mg/0.5 mL injection, 0.5 mL injection device Outdated
sumatriptan 6 mg/0.5 mL injection, 2 x 0.5 mL injection devices Outdated
sumatriptan 6 mg/0.5 mL injection, injection device Outdated
t-PA preparation Nonconformance to editorial policy component
t-PA preparation Nonconformance to editorial policy component
tPA Concept non-current
tRNA CCA-pyrophosphorylase (cytidine) Concept non-current
tRNA cytidylyltransferase Concept non-current
tRNA cytidylyltransferase (substance) Concept non-current
tRNA nucleotidyltransferase Concept non-current
tRNA nucleotidyltransferase (substance) Concept non-current
taches de bougie Erroneous
terHaar dysplasia Not semantically equivalent component
teriparatide 250 microgram / 1 mL injection, 1 x 2.4 mL injection device (medicinal product pack) Outdated
teriparatide 250 microgram / 1 mL injection, 2.4 mL injection device (medicinal product unit of use) Outdated
teriparatide 250 microgram/mL injection, 2.4 mL injection device Outdated
teriparatide 250 microgram/mL, 2.4 mL injection device Outdated
tert-Amyl alcohol Nonconformance to editorial policy component
tert-Butanol Nonconformance to editorial policy component
tert-Butyl acetate Nonconformance to editorial policy component
tert-Butyl acetate (substance) Nonconformance to editorial policy component
tert-Butyl alcohol Nonconformance to editorial policy component
tert-Butyl alcohol (substance) Nonconformance to editorial policy component
tert-Butyl methyl ether Nonconformance to editorial policy component
tert-Butylhydroquinone Nonconformance to editorial policy component
tert-Butylhydroquinone Nonconformance to editorial policy component
tert-Butylhydroquinone (product) Nonconformance to editorial policy component
tert-Butylhydroquinone (substance) Nonconformance to editorial policy component
tert-Pentanol Nonconformance to editorial policy component
tert-Pentyl alcohol Nonconformance to editorial policy component
tert-Pentyl alcohol (substance) Nonconformance to editorial policy component
tetracaine hydrochloride Concept non-current
ther specified pulmonary tuberculosis (disorder) Concept non-current
thiamine nitrate 4.2 mg + riboflavin 4.8 mg + nicotinamide 54 mg + calcium pantothenate 19.6 mg + pyridoxine hydrochloride 6 mg + cyanocobalamin 3 microgram + biotin 450 microgram + folic acid 500 microgram + ascorbic acid 80 mg + cholecalciferol 5 microgram (200 IU) + dl-alpha-tocopheryl acetate 10 mg (10 IU) + calcium 120 mg + chromium 25 microgram + copper 900 microgram + iodine 75 microgram + iron 5 mg + magnesium 45 mg + manganese 1.8 mg + molybdenum 45 microgram + selenium 26 microgram + zinc 8 mg tablet Outdated
thiamine nitrate 4.2 mg + riboflavin 4.8 mg + nicotinamide 54 mg + calcium pantothenate 19.6 mg + pyridoxine hydrochloride 6 mg + cyanocobalamin 3 microgram + biotin 450 microgram + folic acid 500 microgram + ascorbic acid 80 mg + cholecalciferol 5 microgram (200 IU) + dl-alpha-tocopheryl acetate 10 mg (10 IU) + calcium 120 mg + chromium 25 microgram + copper 900 microgram + iodine 75 microgram + iron 5 mg + magnesium 45 mg + manganese 1.8 mg + molybdenum 45 microgram + selenium 26 microgram + zinc 8 mg tablet, 100 Outdated
thou/mcL Concept non-current
tissue plasminogen activator-plasminogen activator inhibitor complex Nonconformance to editorial policy component
tissue plasminogen activator-plasminogen activator inhibitor complex (substance) Nonconformance to editorial policy component
tocilizumab 162 mg / 0.9 mL injection, 0.9 mL injection device (medicinal product unit of use) Outdated
tocilizumab 162 mg / 0.9 mL injection, 1 x 0.9 mL injection device (medicinal product pack) Outdated
tocilizumab 162 mg / 0.9 mL injection, 4 x 0.9 mL injection devices (medicinal product pack) Outdated
tocilizumab 162 mg/0.9 mL injection, 0.9 mL injection device Outdated
tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices Outdated
tocilizumab 162 mg/0.9 mL injection, injection device Outdated
tolnaftate 1% + chlorhexidine hydrochloride 0.25% dusting powder Outdated
tolnaftate 1% + chlorhexidine hydrochloride 0.25% dusting powder, 55 g Outdated
tolnaftate 1% dusting powder Outdated
tolnaftate 1% dusting powder, 20 g Outdated
tolnaftate 1% dusting powder, 60 g Outdated
tolnaftate 10 mg / 1 g dusting powder (medicinal product unit of use) Outdated
tolnaftate 10 mg / 1 g dusting powder, 20 g (medicinal product pack) Outdated
tolnaftate 10 mg / 1 g dusting powder, 60 g (medicinal product pack) Outdated
toxoplasmosis retinitis Erroneous
triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ear ointment Outdated
triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ear ointment, 2.5 g Outdated
triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ear ointment, 5 g Outdated
triamcinolone acetonide 0.1% oromucosal paste Outdated
triamcinolone acetonide 0.1% oromucosal paste, 5 g Outdated
triamcinolone acetonide 1 mg / 1 g oromucosal paste (medicinal product unit of use) Outdated
triamcinolone acetonide 1 mg / 1 g oromucosal paste, 5 g (medicinal product pack) Outdated
tufted mitior Erroneous
turban tumor Concept non-current
turban tumor (morphologic abnormality) Concept non-current
turban tumour Concept non-current
type 2 diabetes mellitus insulin treated Outdated
u/2hr Concept non-current
u/kg Concept non-current
u/kg (qualifier value) Concept non-current
ug/kg/day Concept non-current

Start Previous Page 5841 of 5843 Next End


Reference Sets

Reference set descriptor

Back to Start